Skip to main content
OpenTrials

Clinical trial condition

Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7

Explore clinical trials studying Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 trial results

Active, not recruiting

Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer

NCT01893307

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Florida Health Science Center - Gainesville Gainesville, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
View all 22 locations
View Trial Details
Active, not recruiting

Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer

NCT02567422

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma of Unknown Primary, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 19 locations
View Trial Details
Completed

Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma

NCT02775812

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +17 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Sutter Medical Center Sacramento Sacramento, California, United States
View all 69 locations
View Trial Details
Suspended

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

NCT01810913

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 342 locations
View Trial Details

Related conditions